Clinical Trial Update: A Study Comparing Efficacy of Levodopa-Carbidopa Intestinal Gel/Carbidopa-Levodopa Enteral Suspension and Optimized Medical Treatment on Dyskinesia in Subjects With Advanced Parkinson's Disease (DYSCOVER) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Levodopa-Carbidopa intestinal gel/Carbidopa-Levodopa enteral suspension to optimized medical therapy in advanced Parkinson's disease wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Carbidopa-Levodopa enteral suspension (carbidopa-levodopa enteral suspension)
• Levodopa-carbidopa intestinal gel (levodopa-carbidopa intestinal gel)

Snippet

Sponsor: AbbVie | Conditions: Parkinson's Disease (PD) | Phase 3 | Status: COMPLETED | Results posted: 2020-08-18